Nuvectis Pharma Inc (NVCT)

R&D Expense Growth

14.08%

Quarterly · Period ending:

NVCT logo

NVCT R&D Expense Growth

Latest reported14.08%
NVCT Quarterly R&D Growth (QoQ) (0.00% → 14.08%)
High-resolution chart · PNG

NVCT r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuvectis Pharma Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
14.077%
-19.2686%
-11.9155%
59.8118%
-1.8207%
-18.1495%
59.4892%
-4.2134%
10.6391%
-37.6319%
-4.9264%
5.2557%
80.0591%
-46.1678%
-2.7212%
80.4391%
38.7812%
57.7797%
-72.4735%
-2.0966%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.